Physician profile
Bart Od Lynn
NPI 1457325201
$1,660.31
in general payments reported to CMS, 2019-2025
17 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $192 · 2021: $265 · 2022: $151 · 2023: $240 · 2024: $247 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $366.07 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $324.82 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $267.15 | 2019-2025 | Total30, Tryptyr |
| Bausch & Lomb Americas INC. | $141.46 | 2022-2025 | Miebo, Infuse, Xiidra |
| Oyster Point Pharma, INC. | $118.11 | 2023-2024 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $97.10 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $89.80 | 2024-2025 | Xdemvy |
| Abbvie INC. | $43.19 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.87 | 2020-2021 | |
| Allergan, INC. | $35.42 | 2021-2022 | |
| Biotissue Holdings INC. | $24.07 | 2023 | |
| Alcon Research LLC | $23.84 | 2019 | |
| Kala Pharmaceuticals, INC. | $22.90 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.26 | 2020 | |
| Shire North American Group INC | $16.71 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Derma Sciences, INC. | $14.09 | 2019 | |
| Optos, INC. | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Lynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.